About Positron corporation
Positron Corporation: Revolutionizing Nuclear Medicine Healthcare
Positron Corporation is a leading nuclear medicine healthcare company that specializes in the business of cardiac PET. The company's innovative products and services empower healthcare providers to more accurately diagnose CAD (coronary artery disease) and improve patient outcomes while practicing cost-effective medicine.
With over 30 years of experience in the industry, Positron has established itself as a trusted partner for hospitals, clinics, and research institutions worldwide. The company's mission is to provide cutting-edge solutions that enhance patient care and advance the field of nuclear medicine.
In this article, we will explore Positron Corporation's history, products, services, and achievements. We will also discuss how the company is contributing to the growth of nuclear medicine healthcare globally.
History
Positron Corporation was founded in 1983 by Paul Crowe with a vision to revolutionize nuclear medicine imaging technology. The company started as a small research firm focused on developing new radiopharmaceuticals for PET (positron emission tomography) imaging.
Over time, Positron expanded its operations to include manufacturing and distribution of PET scanners and other related equipment. In 2007, the company acquired Manhattan Isotope Technology LLC (MIT), which gave it access to MIT's proprietary technology for producing medical isotopes.
Today, Positron continues to innovate in the field of nuclear medicine by developing new technologies that improve diagnostic accuracy while reducing costs for patients and providers alike.
Products
Positron offers a range of products designed specifically for cardiac PET imaging. These include:
1. Attrius - A high-performance PET scanner that delivers superior image quality with reduced radiation exposure.
2. CardioGen-82 - A generator-based system that produces rubidium-82 (Rb-82), an FDA-approved radiotracer used in cardiac stress testing.
3. Tech-Assist - A remote monitoring system that allows technicians to monitor scanner performance from anywhere in real-time.
4. Radiopharmaceuticals - Positron manufactures several radiopharmaceuticals used in cardiac PET imaging such as FDG (fluorodeoxyglucose) and N-Ammonia.
Services
In addition to its product offerings, Positron provides various services related to cardiac PET imaging such as:
1. Installation & Training - The company offers installation services for its equipment along with comprehensive training programs designed specifically for each customer.
2. Maintenance & Support - Positron provides ongoing maintenance support through its team of experienced technicians who are available 24/7.
3. Consulting Services - The company offers consulting services related to regulatory compliance issues such as FDA regulations or radiation safety guidelines.
4.Clinical Trials Management – With extensive experience managing clinical trials across multiple therapeutic areas including oncology cardiology neurology among others; positrons clinical trial management team can help you design execute manage your next clinical trial efficiently effectively ensuring timely delivery quality data results
Achievements
Over the years, Positron has achieved several milestones that have contributed significantly towards advancing nuclear medicine healthcare globally:
1.Innovative Technologies – With over three decades’ worth experience innovating developing cutting edge technologies positrons portfolio includes some most advanced systems available today including Attrius high performance pet scanner cardio gen 82 generator based system producing rubidium 82 fdg n ammonia
2.FDA Approval – Several positrons products have received FDA approval including CardioGen-82 Rb-82 generator-based system FDG N-Ammonia
3.Global Presence – With installations across North America Europe Asia Middle East Africa South America; positrons global presence ensures customers receive world class service support wherever they are located
4.Research Collaboration – Through partnerships collaborations leading academic institutions researchers around world; positrons research development efforts continue push boundaries innovation within field
Conclusion
In conclusion ,Positon corporation has been at forefront revolutionizing Nuclear Medicine Healthcare since it was founded over thirty years ago .The Company’s innovative solutions have helped improve diagnostic accuracy reduce costs while enhancing patient care .With an impressive portfolio cutting-edge technologies ,FDA approved products global presence ;positon corporation continues lead way advancing field Nuclear Medicine Healthcare .Whether you’re hospital clinic looking invest latest pet scanning technology or researcher seeking collaborate on ground-breaking study ;positons team experts ready help take your work next level